FINAL HIVQUAL 2007 Benchmark Report 2009 04 21 cgw kls

Cgw02

Description

Report Produced on HIVQUAL-US Performance Data Report April 21, 2009, by Ryan White Part C and Part D Funded Programs Review Period: January 1, 2007 – December 31, 2007 Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator) Eligible Patients, Mean Score and Performance Range Mean Facility Number of Performance Performance 1 2 3patients Score Range (A) ENGAGEMENT IN CARE i. % of patients with a clinical visit every 4 months. 10,005 82.8% 42.9%-100.0% ii. cal visit with an HIV specialist every 4 months. 10,005 73.9% 0.0%-100.0% (B) HIV SPECIFIC INDICATORS CD4 Count i. % of patients with a CD4 count every 4 months. 10,005 63.4% 0.0%-100.0% ii. % of patients with a CD4 count every 6 months. 88.6% Viral Load iii. % of patients with a VL test every 4 months. 10,005 61.7% 0.0%-100.0% iv. every 6 months. 87.4% On HAART v. % of eligible patients on HAART. 9,173 90.9% 23.5%-100.0% vi % of patients with lowest CD4 <200 who were on 2,041 92.5% 0.0%-100.0% HAART. 938 81.3% vii. % of patients with highest VL >100,000 who were on HAART. 1 Total number of patients. 2 Average program score. 3 Throughout this report, sites that did not submit data for an indicator (no eligible patients or declined optional indicator) were excluded from ...

Informations

• Publié par: Orgio
• Nombre de lectures: 33
• Langue: English

Extrait

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)     Eligible Patients, Mean Score and Performance Range    

i.

 i. ii.

iii. iv.

NGAGEMENT IN ARE

% of patients with a clinical visit every 4 months.  

every 4 months.   PECIFIC NDICATORS CD4 Count % of patients with a CD4 count every 4 months. % of patients with a CD4 count every 6 months.

% of patients with a VL test every 4 months. % of patients with a VL test every 6 months.

 

 

1

10,005

10,005

10,005 10,005

10,005 10,005

2

82.8%

73.9%

63.4% 88.6%

61.7% 87.4%

3

Report Produced on April 21, 2009, by  

42.9%-100.0%

0.0%-100.0%

0.0%-100.0% 0.0%-100.0%

0.0%-100.0% 0.0%-100.0%

v. % of eligible patients on HAART.  23.5%-100.0%9,173 90.9%   vi H % A o A f R pa T t . i  entswithlowestCD4<200whowereon 2,041 92.5% 0.0%-100.0%    % of patients 938 81.3% 0.0%-100.0% vii. with highest VL >100,000 who were on   HAART.                                                   1 Total number of patients. 2 3 scoreofysis;adeluxcerewe)orlanatahtmorfdnedecliordntscitaidnnolapoit geraropamgrcosevAer. hTorguohtu  this report, sites that did not submit data for an indicator (no eligible patie 0% means that the indicator was selected by that site but none of the eligible patients received the recommended care. HIVQUAL-US Performance Data Report Page 1 of 24

10,005

10,005

10,005

10,005

the review period who were managed appropriately.

5,421

10,005

viii. % of patients on ARV and clinically stable throughout

7,781

1,574

431

8,515

48.4%

0.0%-100.0%

387

73.1%

67.1%

0.0%-100.0%

0.0%-100.0%

52.9%

0.0%-100.0%

0.0%-100.0%

0.0%-100.0%

60.7%

64.7%

73.2%

64.0%

0.0%-100.0%

10,005



10,005

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)  

HIVQUAL-US Performance Data Report Page 2 of 24

41.1%

0.0%-100.0%

Report Produced on April 21, 2009, by  

mental health screen.

79.7%

 i. % of patients with whom substance use was discussed. 

9,817

2

1

0.0%-100.0%

56.4%

0.0%-100.0%

86.0%

0.0%-100.0%

47.6%

0.0%-95.0%

53.9%

0.0%-100.0%

3

MAC prophylaxis (optional).

10,005

37.9%

0.0%-100.0%

4.4%-100.0%

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)  

i.

  % of patients with TB test completed during the past 24 months. 8,723

syphilis screening.



negative).



   ENERAL EDICAL ARE NDICATORS

i. % of patients with oral health examination.

4 documented in the medical chart (optional).

referred for ophthalmology exam (optional). 



1

10,005

4,753

4,753

10,005

8,515

10,005

10,005

4,783

130

2

69.7%

79.5%

62.2%

62.3%

89.6%

85.3%

82.3%

41.8%

77.4%

21.5%

3

Report Produced on April 21, 2009, by  

0.0%-100.0%

0.0%-100.0%

0.0%-100.0%

0.0%-100.0%

12.5%-100.0%

0.0%-100.0%

14.1%-100.0%

0.0%-100.0%

0.0%-100.0%

0.0%-100.0%

                                                  4   Thus,Of patients with information on pneumococcal vaccination, 92% were missing the date of last vaccination. the original indicator of percentage of patients with documented pneumococcal vaccination in the past 10 years’was changed to ever had a pneumococcal vaccination. ’ HIVQUAL-US Performance Data Report Page 3 of 24

Report Produced on April 21, 2009, by  

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)  

i. % of female patients who received a pelvic examination.



and Pap test.   ATIENT DUCATION NDICATORS  i. % of patients who received any prevention education. 

(optional). 

  i. % of pat

ients who received an anorectal exam.



than 1000 copies/ml and initiated on ARV therapy who received a baseline resistance test.

4,753

4,753

1

10,005

10,005

1,576

10,005

2,444

804

10,005

484

2

71.2%

68.5%

80.0%

56.0%

82.3%

17.4%

12.5%

7.5%

26.1%

43.8%

3

0.0%-100.0%

0.0%-100.0%

0.0%-100.0% 0.0%-100.0%

9.4%-100.0%

0.0%-97.5%

0.0%-100.0%

0.0%-100.0%

0.0%-100.0%

0.0%-100.0%

HIVQUAL-US Performance Data Report Page 4 of 24

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)         Bottom 10%, Median and Top 10% Performance      

 

i.

N

GAGEMENT IN ARE   % of patients with a clinical visit every 4 months. 

every 4 months. 

  CD4 Count i. % of patients with a CD4 count every 4 months. ii. % of patients with a CD4 count every 6 months.

iii. % of patients with a VL test every 4 months. iv. % of patients with a VL test every 6 months.

 v. % of eligible patients on HAART.  vi. % of patients with lowest CD4 <200 who were on HAART.  vii. % of patients with highest VL >100,000 who were on HAART.                                                   5 6 10% of programs fell below this value in performance. 7 s. 10gih.rehulavroemaorencshirfpe Pecnamrofreulavetirapasebhetngm05tootdot%na%ofp50grampro  % of programs achieved t

5

68.7%

42.9%

38.5% 77.2%

38.4% 71.4%

 80.9%  75.0%  50.0%

6

83.5%

80.5%

64.4% 91.2%

62.7% 90.3%

 93.1%  100.0%  90.9%

7

97.1%

94.4%

85.7% 100.0%

83.6% 98.9%

 100.0%  100.0%  100.0%

Report Produced on April 21, 2009, by  

HIVQUAL-US Performance Data Report Page 5 of 24

73.7%

16.7%

4.7%

13.6%

76.6%

70.9%

100.0%

100.0%

73.4%

7.7%

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)  

  viii.

100.0%

84.8%

27.4%

100.0%

Report Produced on April 21, 2009, by  

HIVQUAL-US Performance Data Report Page 6 of 24

55.1%

2.5%

100.0%

100.0%

100.0%

28.3%



0.0%

75.9%

54.1%

28.0%

90.4%

52.5%

0.0%

100.0%

92.3%

5 % of patients on ARV and clinically stable throughout the 44.0%

0.0%

6

7

100.0%

76.3%

50.0%

100.0%

mental health screen.

100.0%

20.9%

100.0%

0.0%

100.0%

61.3%

0.0%

71.4%

 i. % of patients with whom substance use was discussed. 

MAC prophylaxis (optional). 

90.1%

37.7%

Report Produced on April 21, 2009, by  

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)  

 

i.

 CREENING NDICATORS

 

i.

  % of patients with TB test completed during the past 24 months.

syphilis screening.

negative).



  ENERAL EDICAL ARE NDICATORS

% of patients with oral health examination.

(optional). 8 

referred for ophthalmology exam  ( nola.)tiop    



5

33.3%

50.0%

29.2%

29.2%

64.3%

62.3%

45.5%

13.5%

6

75.1%

84.5%

63.6%

63.4%

96.7%

90.5%

93.0%

40.8%

39.3% 84.6%

0.0%

21.5%

7

100.0%

100.0%

100.0%

100.0%

100.0%

100.0%

100.0%

72.9%

98.1% 

71.4%

                                                  8 Of patients with information on pneumococcal vaccination, 92% were missing the date of last vaccination. Thus, the original indicator of percentage of patients with documented pneumococcal vaccination in the past 10 years’was changed to ever had a pneumococcal vaccination’. HIVQUAL-US Performance Data Report Page 7 of 24

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)  

 

   YNECOLOGY  i. % of female patients who received a pelvic examination. 

and Pap test. 

 i. % of patients who received any prevention education.

(optional). 

 ILOT NDICATORS  i. % of patients who received an anorectal exam. 

received an anal Pap smear.



than 1000 copies/ml and initiated on ARV therapy who received a baseline resistance test.

5

45.5%

43.5%

34.3%

2.9%

35.2%

0.00%

0.0%

0.0%

0.0%

0.0%

6

70.0%

67.1%

96.7%

66.7%

91.2%

8.1%

0.0%

0.0%

0.7%

50.0%

7

100.0%

100.0%

100.0% 97.9%

100.0%

100.0%

46.2%

25.0%

96.7%

100.0%

Report Produced on April 21, 2009, by  

HIVQUAL-US Performance Data Report Page 8 of 24

Report Produced on April 21, 2009, by  

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)   The following pages provide visual representations of the top 10% score, mean facility performance score and bottom 10% score for each indicator, organized by category of indicator.   (A) E NGAGEMENT IN C ARE  

% of patients with a clinical visit every 4 months

Top 10%

AVERAGE

Bottom 10%

0%

20% 40%

60%

97.1%

68.7%

82.8%

80% 100%

% patients with a clinical visit with an HIV specialist every 4 months

Top 10%

AVERAGE

Bottom 10%

0%

20%

40%

42.9%

60%

94.4%

73.9%

80%

100%

  i.

  ii.

HIVQUAL-US Performance Data Report Page 9 of 24

 

AVERAGE

63.4%

AVERAGE

Bottom 10%

80% 100%

40% 60%

38.5%

20%

60%

40%

20%

0%

Top 10%

85.7%

Top 10%

Bottom 10%

% of patients with CD4 every 6 months

0%

61.7%

38.4%

83.6%

98.9%

Top 10%

100.0%

Bottom 10%

0%

% of patients with a viral load test every 6 months

  i.  

80%

100%   iii.  

20%

40% 60%

AVERAGE

Top 10%

88.6%

AVERAGE

77.2%

80% 100% ii.  

 

% of patients with CD4 count every 4 months

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)   (B) HIV   S PECIFIC I ACIDNSROT    

% of patients with a viral load test every 4 months

Bottom 10%

87.4%

71.4%

Report Produced on April 21, 2009, by  

0%

20%

  iv.    

40%

60% 80% 100%

HIVQUAL-US Performance Data Report Page 10 of 24

Report Produced on April 21, 2009, by  

HIVQUAL-US Performance Data Report Ryan White Part C and Part D Funded Programs    Review Period:January 1, 2007  December 31, 2007  Data submissions from 168 facilities, representing 93 Ryan White Part C or D grantees (number varies by indicator)  

HIVQUAL-US Performance Data Report Page 11 of 24

80.9%

Bottom 10%

90.9%

AVERAGE

Top 10%

100.0%

% of patients with highest VL>100,000 who were on HAART

% of eligible patients on HAART

100.0%

% of patients on ARV and clinically stable throughout the review period who were managed appropriately

80% 100%

vii.  

60%

40%

20%

0%

% of patients with lowest CD4<200 who were on HAART 

Bottom 10%

0%

20%

40%

60%

80% 100%

 

75.0%

80% 100%   vi.  

60%

Bottom 10%

Top 10%

100.0%

92.5%

AVERAGE

80%

20%

100%

viii.

0%

44.0%

60%

40%

50.0%

AVERAGE

AVERAGE

81.3%

20%

40%

Bottom 10%

0%

Top 10%

Top 10%

100.0%

73.1%